We are live on ! Find out more
SSKN

Strata Skin Sciences

Delisted

SSKN was delisted on the 18th of February, 2026.

26 hedge funds and large institutions have $1.6M invested in Strata Skin Sciences in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.88% more ownership

Funds ownership: 20.82% → 24.7% (+3.9%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

4% less funds holding

Funds holding: 27 → 26 (-1)

22% less capital invested

Capital invested by funds: $2.07M → $1.6M (-$465K)

Holders
26
Holders Change
-1
Holders Change %
-3.7%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SSKN Hedge Fund Activity: Q2 2016 in Review

26 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q2 2016, worth a combined $1.6M — down 22% from $2.07M a quarter earlier.

Fund positioning in SSKN was balanced in Q2 2016: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 6 trimmed.

The largest buyer was Sabby Management, adding an estimated $360K. The largest seller was Broadfin Capital, cutting an estimated $37.8K.

  • 26 institutional investors held Strata Skin Sciences (SSKN) as of Q2 2016, down from 27 in Q1 2016.
  • Funds reported $1.6M of Strata Skin Sciences stock for Q2 2016, down 22% quarter-over-quarter.
  • 4 funds opened new Strata Skin Sciences positions in Q2 2016 and 4 closed out, a net change of 0 holders.
  • The largest Strata Skin Sciences buyer in Q2 2016 was Sabby Management, an estimated $360K added.
  • The largest Strata Skin Sciences seller in Q2 2016 was Broadfin Capital, an estimated $37.8K sold.

Based on aggregated 13F filings for Q2 2016.